| Category | Details |
|---|---|
| Event | Launch of NexCAR19, India's first indigenous CAR T-cell therapy |
| Developed By | ImmunoACT (IIT Bombay incubated startup) |
| Collaborators | Tata Memorial Hospital, IIT Bombay, DBT, BIRAC |
| Supported By | Department of Biotechnology (DBT) and Biotechnology Industry Research Assistance Council (BIRAC) |
| Launched By | Prime Minister Narendra Modi |
| Launch Date | November 2025 |
| Therapy Type | CAR (Chimeric Antigen Receptor) T-cell therapy |
| Target Cancers | B-cell leukemia and lymphoma |
| Treatment Process | Collection → Engineering → Multiplication → Infusion |
| Significance | - First of Its Kind in India |
| - Make in India in Biotech | |
| - Global Competitiveness (joins US, China, Germany) | |
| - Public-Private Research Collaboration | |
| Implications | - Hope for relapsed patients |
| - Personalized cancer treatment | |
| - Reduced financial burden | |
| - Access to advanced therapy within India |
Workflow
Login
Contact Counsellor